The bill
Protect Children’s Innocence Act
HR. 3492, 119th Congress — read as touching Medical Devices.
Sponsored by
Rep. Greene, Marjorie Taylor [R-GA-14]
ID: G000596
Follow the money
The bill
HR. 3492, 119th Congress — read as touching Medical Devices.
The sponsor
Every bill has someone who introduced it. That name is where the paper trail starts.
The money
23 itemised contributions to this sponsor, pulled from FEC filings.
Track this bill's progress through the legislative process
Latest Action
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
December 17, 2025
📍 Current Status
Next: Both chambers must agree on the same version of the bill.
1. Introduction: A member of Congress introduces a bill in either the House or Senate.
2. Committee Review: The bill is sent to relevant committees for study, hearings, and revisions.
3. Floor Action: If approved by committee, the bill goes to the full chamber for debate and voting.
4. Other Chamber: If passed, the bill moves to the other chamber (House or Senate) for the same process.
5. Conference: If both chambers pass different versions, a conference committee reconciles the differences.
6. Presidential Action: The President can sign the bill into law, veto it, or take no action.
7. Became Law: If signed (or if Congress overrides a veto), the bill becomes law!
[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 3492 Referred in Senate (RFS)]
<DOC> 119th CONGRESS 1st Session H. R. 3492
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
December 18, 2025
Received; read twice and referred to the Committee on the Judiciary
______________________________________________________...
Rep. Greene, Marjorie Taylor [R-GA-14]
Congress 119 • 2024 Election Cycle
No PAC contributions found
No committee contributions found
This bill has 10 cosponsors. Below are their top campaign contributors.
ID: C001132
Top Contributors
10
ID: F000475
Top Contributors
10
ID: L000596
Top Contributors
0
No contribution data available
ID: B000740
Top Contributors
10
ID: M001211
Top Contributors
10
ID: C001120
Top Contributors
10
ID: M001239
Top Contributors
0
No contribution data available
ID: K000392
Top Contributors
10
ID: B001302
Top Contributors
10
ID: B001316
Top Contributors
10
Hub layout: Politicians in center, donors arranged by type in rings around them.
Showing 62 nodes and 35 connections (50 secondary connections hidden)
Total contributions: $192,460
Showing top 20 donors by contribution amount
Which industries are materially affected by specific provisions in this bill. 4 harmed.
Section 2(a)-(b) criminalizes performing or attempting genital or bodily mutilation or chemical castration on a minor, which includes surgeries such as mastectomy, orchiectomy, hysterectomy, and other procedures listed in subsection (h)(1)(B)-(F). This directly impacts medical device manufacturers that produce implants, surgical tools, and related equipment used in gender-affirming procedures, imposing a clear cost via prohibition and criminal penalties.
Section 2(b) and (h)(2) define and prohibit chemical castration of a minor, including administering GnRH analogues, testosterone, or estrogen for the purposes of altering biological sex. This directly impacts pharmaceutical manufacturers that produce puberty-blocking drugs and hormone therapies, imposing a clear cost via criminal penalties for prescribing, dispensing, or distributing such medications to minors.
Sections 2(a)-(c) prohibit genital/bodily mutilation and chemical castration of minors, with limited medical exceptions in subsection (g). Hospitals and health systems that provide gender-affirming care (including surgeries and hormone treatments) would face criminal liability for performing such procedures outside the narrow exceptions, imposing a clear regulatory and legal cost.
Biotech firms developing or manufacturing puberty-blocking drugs, hormone therapies, or related biologics (e.g., GnRH analogues) are directly impacted by the prohibition on chemical castration in subsection (b) and (h)(2). The criminal penalties for prescribing/distributing such drugs to minors impose a clear cost on this industry.
For each industry this bill affects, here's what the sponsor (Rep. Greene, Marjorie Taylor [R-GA-14])received from donors associated with that industry during the 2022–present cycles. Donations are not proof of intent — they are a record of who funds the people writing the law.
Promptly Ending Political Prosecutions and Executive Retaliation Act of 2025
A joint resolution proposing an amendment to the Constitution of the United States to limit the number of terms an individual may serve as a Member of Congress.
Tax Court Improvement Act